Project Grant R21DA064861
- Federal Project Grant Award Summary The University of Texas at Austin received a $1.21 million Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded August 1, 2025, with completion targeted for April 30, 2028. This research initiative develops rigorous methodologies for evaluating and comparing large-scale computational brain models against massive neural activity datasets. The project addresses a critical gap in...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The University of Texas Health Science Center at San Antonio a $163,350 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective February 15, 2026, with completion targeted for January 31, 2028. This award supports basic research investigating the molecular regulation of the kappa opioid receptor (KOR) by 14-3-3 gamma protein in peripheral neurons. The research aims to understand the...
- Federal Project Grant Award Summary The University of Texas at Austin received a $159,625 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning July 1, 2025, and concluding June 30, 2027. This award supports basic research investigating age and sex differences in reward responding following punishment exposure, with the ultimate objective of establishing whether punishment serves as an effective deterrent for...
- Federal Grant Award Summary Texas A&M University received a $124,215 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 11, 2026, with a completion date of February 28, 2029. The research project, titled "Circadian Encoding of Reward-Seeking Behavior in the Mesolimbic Dopamine Pathway," will investigate the integration of circadian rhythms into neural circuitry governing reward-seeking...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded $651,468 to the University of Texas at Austin on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop, evaluate, and disseminate StatWiseAI, an artificial intelligence-powered educational tool designed to enhance methodological rigor in analyzing complex, large-scale datasets. The three-year project, scheduled for completion by August 31, 2028, addresses the critical gap...
- Federal Project Grant Award Summary Texas A&M University System Health Science Center received a $675,247 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 15, 2026, with completion targeted for March 31, 2031. This research project investigates cholinergic dysregulation mechanisms underlying cognitive inflexibility in cocaine use disorder, with particular focus on how cocaine-induced neural adaptations...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Texas Medical Branch at Galveston a $1.59 million Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to support discovery and development of small molecule ligand probes targeting GPR52, a novel orphan G protein-coupled receptor identified as a promising therapeutic target for cocaine use disorder (CUD). The research project, initiated September 1, 2025, and scheduled for...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant totaling $490,179 to the University of Texas at Austin on May 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate the neurobiological mechanisms underlying fentanyl-induced elevations in risk-taking behavior. The research addresses a critical gap in understanding opioid use disorder relapse by examining how synthetic opioids impair decision-making...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded UC San Diego a $197,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2027. The award supports development and validation of an in vivo Massively Parallel Reporter Assay (MPRA) methodology to characterize the functional role of cis-regulatory elements and genetic variants associated with substance use disorders. Specifically, the...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $2.29 million Project Grant (CFDA 93.279, Drug Use and Addiction Research Programs) to the Texas Biomedical Research Institute in San Antonio, Texas, effective August 15, 2025, with completion expected by May 31, 2030. This research project develops novel CRISPR/Cas genome editing therapeutic approaches to eliminate Simian Immunodeficiency Virus (SIV) reservoirs in the central nervous system (CNS) of...
The University of Texas at San Antonio received a $185,279 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) for the period July 1, 2026, through June 30, 2028. The award supports research titled "Targeting the Midbrain Astrocyte Epigenome to Regulate Drug-Dependent Behavior," which investigates how abused substances alter gene regulation in ventral tegmental area astrocytes—non-neuronal brain cells that play a modulatory role in drug intake and drug-seeking behavior. The research leverages chromatin accessibility analysis and transcriptional profiling to identify drug-mediated epigenetic alterations in response to cocaine, psychostimulants, and opioids, with the objective of manipulating these regulatory elements to suppress drug-dependent behaviors. The project delivers fundamental neuroscience research outputs examining the molecular mechanisms underlying addiction, with emphasis on characterizing the time course of chromatin and transcriptional changes in midbrain astrocytes following drug exposure. This work extends current understanding beyond established research on nucleus accumbens astrocytes to explore a distinct neurobiological pathway relevant to the National Institute on Drug Abuse's mission to develop new knowledge and approaches for the prevention, diagnosis, and treatment of drug use, misuse, and addiction.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $185.3k | 7/1/26 |